Hanny Al-Samkari, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Avatrombopag vs. Placebo for CIT in GI Malignancies (NCT05772546) | Hanny Al-Samkari, MD | 2023-11-01 |
| Bevacizumab In Hereditary Hemorrhagic Telangiectasia (NCT04404881) | Hanny Al-Samkari, MD | 2020-11-23 |
Track Hanny Al-Samkari, MD automatically
Every clearance here is in the API, with alerts when new ones post.